Citation Impact
Citing Papers
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells
2016
Challenges of e-Learning during the COVID-19 Pandemic Experienced by EFL Learners
2020 Standout
Mycoplasma pneumoniae triggering the Guillain‐Barré syndrome: A case‐control study
2016
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells
2020 StandoutNobel
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
2008
Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
2012
Carbohydrate mimicry: a new paradigm of autoimmune diseases
2005
Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain–Barré syndrome and Miller Fisher syndrome
2012
Protein-glycan interactions in the control of innate and adaptive immune responses
2008
Guillain-Barré syndrome
2016 Standout
IgG Fc Glycosylation in Human Immunity
2019
Guillain-Barre syndrome subtypes related to Campylobacter infection
2011
Guillain–Barré Syndrome
2012 Standout
Tissue-resident macrophages
2013 Standout
Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity
2013
Siglecs at the Host–Pathogen Interface
2020
Biological roles of glycans
2016 Standout
Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review
2009
Glycolipid antigens and autoantibodies in autoimmune neuropathies
2013
Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs
2018
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Siglecs as sensors of self in innate and adaptive immune responses
2012
Neutrophil extracellular traps in immunity and disease
2017 Standout
Comprehensive Analysis of Bacterial Risk Factors for the Development of Guillain‐Barré Syndrome afterCampylobacter jejuniEnteritis
2006
Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction
2011
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
2015
Axonal Guillain-Barré syndrome: concepts and controversies
2013
Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice
2009 StandoutNobel
Vaccines and Guillain-Barré Syndrome
2009
Synthesis and biological evaluation of 9-N-oxamyl sialosides as Siglec-7 ligands
2015
Dendritic Cells: A Spot on Sialic Acid
2013
Ganglioside mimicry as a cause of Guillain–Barré syndrome
2005
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
2014
The interplay between Siglecs and sialylated pathogens
2014
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Guillain-Barré syndrome
2005 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Glycoproteomics
2022 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway
2021 StandoutNobel
Enhanced, Sialoadhesin-Dependent Uptake of Guillain-Barré Syndrome-Associated Campylobacter jejuni Strains by Human Macrophages
2013
Genetics of Guillain‐Barré syndrome (GBS ) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP ): current knowledge and future directions
2014
The occurrence of Guillain-Barre syndrome within families
2004
European consensus proposal for immunoglobulin therapies
2014
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
Markers for Guillain‐Barré syndrome with poor prognosis: a multi‐center study
2017
Characterization of the Specific Interaction between Sialoadhesin and Sialylated Campylobacter jejuni Lipooligosaccharides
2010
Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus
2014
Sialoadhesin Promotes Rapid Proinflammatory and Type I IFN Responses to a Sialylated Pathogen, Campylobacter jejuni
2012
Global Epidemiology of Campylobacter Infection
2015 Standout
Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells
2016
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Paraparetic Guillain-Barré syndrome
2014
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
2015
Immunoglobulin G Fc N-glycosylation in Guillain-Barré syndrome treated with intravenous immunoglobulin
2014
Works of Wouter van Rijs being referenced
IgG Fc N-Glycosylation in Guillain–Barré Syndrome Treated with Immunoglobulins
2014
Effect of glucocorticoid receptor gene polymorphisms in Guillain‐Barré syndrome
2009
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain–Barré patients
2004
Sialylation of Campylobacter jejuni Lipo-Oligosaccharides: Impact on Phagocytosis and Cytokine Production in Mice
2012
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain–Barré syndrome
2008
Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy
2013
Guillain-Barré Syndrome-Related Campylobacter jejuni in Bangladesh: Ganglioside Mimicry and Cross-Reactive Antibodies
2012
Genetic polymorphisms of macrophage-mediators in Guillain–Barré syndrome
2007
Mannosylated PLP139–151 induces peptide-specific tolerance to experimental autoimmune encephalomyelitis
2005
Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain–Barré syndrome
2005
Susceptibility to Guillain–Barré syndrome is not associated with CD1A and CD1E gene polymorphisms
2008
Innate I mmunity to C ampylobacter jejuni in G uillain‐B arré S yndrome
2015
Mannose-Binding Lectin Contributes to the Severity of Guillain-Barre Syndrome
2006
Sialylation of Campylobacter jejuni Endotoxin Promotes Dendritic Cell–Mediated B Cell Responses through CD14-Dependent Production of IFN-β and TNF-α
2013
TLR4-Mediated Sensing of Campylobacter jejuni by Dendritic Cells Is Determined by Sialylation
2010
Campylobacter jejuni Lipooligosaccharides Modulate Dendritic Cell-Mediated T Cell Polarization in a Sialic Acid Linkage-Dependent Manner
2011